Zobrazeno 61 - 70
of 177
pro vyhledávání: '"Colloca A"'
Publikováno v:
Asia-Pacific journal of clinical oncologyREFERENCES. 16(4)
Background Neutrophil count reduction after chemotherapy has been related with longer survival of patients with metastatic pancreatic adenocarcinoma, but there is not a standardized measurement for this phenomenon. Methods Some parameters related to
Publikováno v:
Clinicalexperimental metastasis. 36(6)
The primary tumor site of pancreatic cancer has been suggested as a recommended variable in future studies of treatments of patients with unresectable or metastatic pancreatic adenocarcinoma (mPDAC). The aim of the current study is to analyze the dif
Publikováno v:
International journal of clinical oncology. 24(11)
Tumor radiologic response after systemic chemotherapy has been used as endpoint of trials of patients with metastatic colorectal cancer (mCRC), which can report the best overall response rate (ORR) and the disease control rate (DCR) by RECIST criteri
Autor:
Mari A. Griffioen, Amol C. Shetty, Shijun Zhu, Anup Mahurkar, Hyungsuk Kim, Heather Huot-Creasy, Carrie McCracken, Cameron B Lassiter, Debra E. Lyon, Cynthia L. Renn, Wendy A. Henderson, Leorey N. Saligan, Angela Starkweather, Colleen Jackson-Cook, Luana Colloca, Susan G. Dorsey, Jessica Gill
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216539 (2019)
The mechanisms underlying the transition from acute to chronic pain remain unclear. Here, we sought to characterize the transcriptome associated with chronic low back pain as well as the transcriptome of the transition from acute to chronic low back
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffcae82d91ea2a1409721ab75dc9af52
https://europepmc.org/articles/PMC6522025/
https://europepmc.org/articles/PMC6522025/
Ancillary factors, not directly related to treatment, often play a significant role by affecting therapeutic outcome. A search of the literature was conducted including words related to the placebo phenomenon and orofacial diseases. Therefore, critic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53123b04113ecf46e309b1d6149f0ea5
https://europepmc.org/articles/PMC6331285/
https://europepmc.org/articles/PMC6331285/
Publikováno v:
Medical Oncology. 35
Inflammation is known to play an important role in the biology of metastatic pancreatic adenocarcinoma (mPDAC), and systemic inflammatory response (SIR) is reported to be closely related to outcome in mPDAC. The aim of the present paper is to assess
Publikováno v:
International journal of clinical oncology. 24(3)
Early tumor shrinkage (ETS) is a response-related endpoint of clinical trials of chemotherapy (CHT) of patients with metastatic colorectal cancer (mCRC). It identifies a dimensional reduction of tumor size by at least 20–30% after 6–8 weeks of CH
Autor:
Stefano Colloca, Alfredo Nicosia, Anders Gorm Pedersen, Silmi Mariya, Anne-Marie C. Andersson, Riccardo Cortese, Joko Pamungkas, Diah Iskandriati, Robert D Burk, Peter Johannes Holst, Emeline Ragonnaud, Antonella Folgori
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 40(2)
Currently available prophylactic vaccines have no therapeutic efficacy for preexisting human papillomavirus (HPVs) infections, do not target all oncogenic HPVs and are insufficient to eliminate the burden of HPV induced cancer. We aim to develop an a
Publikováno v:
Clinical Genitourinary Cancer. 14:5-11
Prostate cancer is the second most common malignancy of men in the western countries. Fatigue is the most stressful symptom of which patients with metastatic castration-resistant prostate cancer (mCRPC) complain. The aim of this article was to report
Publikováno v:
British Journal of Medicine and Medical Research. 11:1-9